Bay Street News, December, 2024

Evaluating strategic options for iopofosine I 131 a late-stage clinical program with compelling Phase 2 data and a substantial market […]

MONTRÉAL, Dec. 10, 2024 (GLOBE NEWSWIRE) — Premier Health of America Inc. (TSXV: PHA) (the “Corporation”), a leading Canadian Healthtech […]

SAN JOSE, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) — Nutanix, Inc. (“Nutanix”) (Nasdaq: NTNX), a leader in hybrid multicloud computing, […]

BROOKFIELD, NEWS, Dec. 10, 2024 (GLOBE NEWSWIRE) — Brookfield Corporation (“Brookfield”) (NYSE: BN, TSX: BN) today announced the pricing of […]

NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) — New York Mortgage Trust, Inc. (Nasdaq: NYMT) (the “Company”) announced today that […]

NAARDEN, The Netherlands and MIAMI, Dec. 10, 2024 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the […]

MIAMI, Fla. and BANGKOK, Dec. 10, 2024 (GLOBE NEWSWIRE) — Arogo Capital Acquisition Corp. (“Arogo Capital”) (OTC: AOGO) today announced […]

Phase 2b/3 trial of izokibep did not meet primary endpoint; secondary endpoints also did not achieve statistical significance Company continues […]

NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) — Cellectis (Euronext Growth: ALCLS – NASDAQ: CLLS) (the “Company”), a clinical-stage biotechnology company […]

ROUYN-NORANDA, Quebec, Dec. 10, 2024 (GLOBE NEWSWIRE) — Abcourt Mines Inc. (“Abcourt” or the “Corporation”) (TSX Venture: ABI) (OTCQB: ABMBF) is […]